Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download ChromeDownload Microsoft Edge
Press release

Issue of New Ordinary Shares and Total Voting Rights

Sensyne Health plc (LSE:SENS) ("Sensyne" or the "Company") today announces that it has issued a total of 236,625 new ordinary shares of ten pence nominal value ("New Ordinary Shares") to the US health systems St. Luke's University Health Network (St. Luke's) and Sentara Healthcare (“Sentara”).

April 4, 2022

These New Ordinary Shares have been issued under the terms of the previously announced strategicresearch agreements (SRAs) and follow the completion of a valuation exercise as required underSection 593 of the Companies Act.

Allocations were made as follows:

Health System New Ordinary Shares Allocated
St Luke’s 115,541
Sentara 121,084
Total 236,625

Application has been made to the London Stock Exchange for the admission of the 236,625 New Ordinary Shares to trading on AIM and it is expected that admission will become effective and that dealings will commence at 8.00 a.m. on 7th April 2022.

Total Voting Rights

Following the allotment of the New Ordinary Shares, the total number of ordinary shares following admission will be 166,464,335 with each ordinary share carrying the right to one vote. The Company has no shares in Treasury; therefore, following admission the total number of voting rights in Sensyne will be 166,464,335. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify an interest in, or change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Press release

Issue of New Ordinary Shares and Total Voting Rights

April 4, 2022
Sensyne Health plc (LSE:SENS) ("Sensyne" or the "Company") today announces that it has issued a total of 236,625 new ordinary shares of ten pence nominal value ("New Ordinary Shares") to the US health systems St. Luke's University Health Network (St. Luke's) and Sentara Healthcare (“Sentara”).

These New Ordinary Shares have been issued under the terms of the previously announced strategicresearch agreements (SRAs) and follow the completion of a valuation exercise as required underSection 593 of the Companies Act.

Allocations were made as follows:

Health System New Ordinary Shares Allocated
St Luke’s 115,541
Sentara 121,084
Total 236,625

Application has been made to the London Stock Exchange for the admission of the 236,625 New Ordinary Shares to trading on AIM and it is expected that admission will become effective and that dealings will commence at 8.00 a.m. on 7th April 2022.

Total Voting Rights

Following the allotment of the New Ordinary Shares, the total number of ordinary shares following admission will be 166,464,335 with each ordinary share carrying the right to one vote. The Company has no shares in Treasury; therefore, following admission the total number of voting rights in Sensyne will be 166,464,335. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify an interest in, or change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Press release

Issue of New Ordinary Shares and Total Voting Rights

Issue of New Ordinary Shares and Total Voting Rights

April 4, 2022
Sensyne Health plc (LSE:SENS) ("Sensyne" or the "Company") today announces that it has issued a total of 236,625 new ordinary shares of ten pence nominal value ("New Ordinary Shares") to the US health systems St. Luke's University Health Network (St. Luke's) and Sentara Healthcare (“Sentara”).

These New Ordinary Shares have been issued under the terms of the previously announced strategicresearch agreements (SRAs) and follow the completion of a valuation exercise as required underSection 593 of the Companies Act.

Allocations were made as follows:

Health System New Ordinary Shares Allocated
St Luke’s 115,541
Sentara 121,084
Total 236,625

Application has been made to the London Stock Exchange for the admission of the 236,625 New Ordinary Shares to trading on AIM and it is expected that admission will become effective and that dealings will commence at 8.00 a.m. on 7th April 2022.

Total Voting Rights

Following the allotment of the New Ordinary Shares, the total number of ordinary shares following admission will be 166,464,335 with each ordinary share carrying the right to one vote. The Company has no shares in Treasury; therefore, following admission the total number of voting rights in Sensyne will be 166,464,335. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify an interest in, or change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Press release

Issue of New Ordinary Shares and Total Voting Rights

Sensyne Health plc (LSE:SENS) ("Sensyne" or the "Company") today announces that it has issued a total of 236,625 new ordinary shares of ten pence nominal value ("New Ordinary Shares") to the US health systems St. Luke's University Health Network (St. Luke's) and Sentara Healthcare (“Sentara”).

These New Ordinary Shares have been issued under the terms of the previously announced strategicresearch agreements (SRAs) and follow the completion of a valuation exercise as required underSection 593 of the Companies Act.

Allocations were made as follows:

Health System New Ordinary Shares Allocated
St Luke’s 115,541
Sentara 121,084
Total 236,625

Application has been made to the London Stock Exchange for the admission of the 236,625 New Ordinary Shares to trading on AIM and it is expected that admission will become effective and that dealings will commence at 8.00 a.m. on 7th April 2022.

Total Voting Rights

Following the allotment of the New Ordinary Shares, the total number of ordinary shares following admission will be 166,464,335 with each ordinary share carrying the right to one vote. The Company has no shares in Treasury; therefore, following admission the total number of voting rights in Sensyne will be 166,464,335. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify an interest in, or change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Arrange to meet us
Press release

Issue of New Ordinary Shares and Total Voting Rights

April 4, 2022
Sensyne Health plc (LSE:SENS) ("Sensyne" or the "Company") today announces that it has issued a total of 236,625 new ordinary shares of ten pence nominal value ("New Ordinary Shares") to the US health systems St. Luke's University Health Network (St. Luke's) and Sentara Healthcare (“Sentara”).

These New Ordinary Shares have been issued under the terms of the previously announced strategicresearch agreements (SRAs) and follow the completion of a valuation exercise as required underSection 593 of the Companies Act.

Allocations were made as follows:

Health System New Ordinary Shares Allocated
St Luke’s 115,541
Sentara 121,084
Total 236,625

Application has been made to the London Stock Exchange for the admission of the 236,625 New Ordinary Shares to trading on AIM and it is expected that admission will become effective and that dealings will commence at 8.00 a.m. on 7th April 2022.

Total Voting Rights

Following the allotment of the New Ordinary Shares, the total number of ordinary shares following admission will be 166,464,335 with each ordinary share carrying the right to one vote. The Company has no shares in Treasury; therefore, following admission the total number of voting rights in Sensyne will be 166,464,335. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify an interest in, or change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.